Notice of Zealand Pharma ’s Interim Report for Q1 2013
5/8/2013 9:58:57 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Copenhagen, 2013-05-08 10:21 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (“Zealand”) a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, informs that its interim report for the first quarter of 2013 in accordance with the Financial Calendar will be announced on Wednesday morning, 15 May 2013.
Help employers find you! Check out all the jobs and post your resume.